In colorectal cancer, SOX2 has been shown to work with TM4SF1 to maintain cancer cell stemness and epithelial-mesenchymal transition (EMT) 2, and thus, may be a new potential biomarker 3. This evidence concerns the gene SOX2 and cancer.